OptimizeRx CorporationOPRXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-22.4%
5Y CAGR-27.4%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-22.4%/yr
vs -4.6%/yr prior
5Y CAGR
-27.4%/yr
Recent acceleration
Acceleration
-17.7pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20252.10+78.3%
20241.18-68.5%
20233.75-16.7%
20224.50-72.0%
202116.08+54.1%
202010.43+115.3%
20194.85-10.8%
20185.43+60.2%
20173.39+54.4%
20162.20-